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Background: Streptococcus pneumoniae (SP) is the major cause of childhood mortality worldwide, we need to
understand virulence genes of SP so can better target the treatment.
We investigated the expression of virulence genes PsaA and CpsA in different strains of SP interacting with
monocyte cell line (THP-1) or pneumocyte cell line (A549) and the possible mechanism of SP invasion of the
blood system.
Methods: A total of 23 strains of SP were collected from hospitalized patients (blood-derived and sputum-derived)
in the Second Affiliated Hospital of Wenzhou Medical College. The strains and ATCC 49619 were cultured, and RNAs
were extracted. THP-1 and A549 cells were stimulated by different SP and ATCC 49619 for 4 h and 8 h, respectively.
Quantitative real-time PCR was used to analyze the mRNA expression of PsaA and CpsA. The data were analyzed by
SPSS 17.0.
Results: The mRNA level of PsaA and CpsA were all significantly increased in clinical SP strains when compared to
ATCC49619 after tedTHP-1 and A549 cells were stimulated. Clinical SPs showed higher virulence compared with
ATCC49619.
Conclusions: The expression of CpsA is the basis of the pathogenicity of SP. The expression of virulence gene PsaA
may be helpful to the invasion of SP to the blood system.
Keywords: Streptococcus pneumonia, Real-time PCR, Virulence gene, PsaA, CpsABackground
Streptococcus pneumoniae (SP) is a class of the most
common pathogens and is a leading cause of death for
young children in developing countries. It is the patho-
genic bacteria of community-acquired pneumonia, otitis
media, meningitis, abscesses and so on, with infants and
the elderly as the susceptible populations [1]. In develop-
ing countries, there are one million children younger
than 5 years who die of pneumonia each year, and SP is
one of the most fatal pathogens [2]. With high morbidity
and mortality, SP is the most common pathogen present* Correspondence: JinZhang@sina.com; lixiangyang29@163.com
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reproduction in any medium, provided the orin the upper respiratory tract of asymptomatic carriers
[3]; a variety of ingredients of SP such as capsule and
other virulence factors could stimulate the immune
response when SP changes from colonization to patho-
genicity, especially during the process of blood or cerebro-
spinal fluid infection [4-6]; and various immune cells-such
as neutrophils, monocytes/macrophages and dendritic
cells-are involved in the process and release a variety of re-
sponse factors simultaneously [7-9].
The proportion of septicemia and meningitis infections
caused by SP accounts for about 5% in total SP infections,
while the risk is much higher than other types with the fa-
tality rate nearly exceeding 30% [10,11]. Some studies have
reported on the mechanism of SP invasion of the blood
system and nervous system; Uchiyama [6] reported that
NanA was a virulence factor contributing to SP invasionThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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kinds of virulence factors have been found in SP, such as
NanA, CpsA, CbpA, PsaA, PspA, PspC and Ply, etcetera
[2], each one has different bioactivity, and each can cause
different types of SP infections [6,12,13].
Monocytes and pneumocytes are host defense cells in
SP infections, and are commonly used for study of patho-
genesis of SP infections [8,9]. In the current study, 23 clin-
ical (blood-derived and sputum-derived) SP strains were
isolated from hospitalized patients, and the representative
SP virulence factors-PsaA and CpsA-were analyzed to ex-
plore the possible invasive mechanism of SP into blood
system.
Methods
Bacterial strains and cell lines
SP standard strain ATCC49619 was provided by the
Chinese National Center for Medical Culture Collections.
Twenty-three clinical SP strains were isolated from the in-
patients in the Second Affiliated Hospital, Wenzhou
Medical College, in 2009. Written informed consent was
obtained from each patient for the use of their clinical
sample. The study was approved by the Institutional
Ethnic Review Board of the Taizhou Municipal Hospital.
SP infection diagnosis was confirmed by the hospital phy-
sicians based on the clinical symptoms and laboratory
findings, whereas the polymerase chain reaction (PCR)
test was used for the detection of Pbp2B [14] gene in SP.
A total of 23 non-duplicate strains were screened, 11 of
them were isolated from specimens of blood, known as
blood-derived SP and 12 strains were from sputum speci-
mens, known as sputum-derived SP. All strains were identi-
fied to species by GPI Card of VITEK-32 automated
microbial analyzer (bioMérieux Inc., Marcy-Etoile, France),
and confirmed according to du Plessis [15] who reported
an SP-specific PCR assay (target gene Pbp2B, forward
primer: 5′-CTGACCATTGATTTGGCTTTCCAA-3′; re-
verse primer: 5′-TTTGCAATAGTTGCTACATACTG-3′,
the length of purpose gene is 682 bp).
THP-1 and A549 cells were purchased from ATCC
(Manassas, VA, USA). THP-1 cells were routinely
maintained in RPMI 1640 medium, and A549 cells were
maintained in F-12K medium, with 1% streptomycin,
1% penicillin and 10% fetal bovine serum (FBS) in a 5%
CO2 incubator at 37°C. Both cell lines were adjusted to
3 × 108/L for the experiment. 23 strains of SP were cul-
tured and sublimated in normal saline at 1 and 2
Mcfarland for the cell stimulation test.
Cell stimulation test
THP-1 cells were grown in 48-well plates with 105 cells
per well. A total of 100 μL of SP bacterial suspension with
the concentration of 1.0 Mcfarland or 100 μL of normal
saline as control was added into the plates. The cells werecollected in 1.5 ml tubes by centrifugation (4000 rpm, 10
min) for RNA extraction immediately or stored in −80°C
after culture in a 5% CO2 incubator at 37°C for 4 h or 8 h
respectively. The method of the A549 cell stimulation test
was the same as above.
RNA extraction and real-time RT-PCR analysis
Total RNA was extracted with purified RNA-extracting
reagent (Takara Biological Engineering Co., Ltd. Dalian,
China). The purity of RNA was determined using a
Nanodrop 2000 spectrophotometer, and OD260/OD280
values of the samples were approximately 1.8 to 2.2. Real-
time RT-PCR was performed to detect transcripts of viru-
lence gene (PsaA and CpsA), and the 16s rRNA of GAPDH
was used as the endogenous control gene. The forward
primer of PsaA [16] was 5′GGTACATTACTCGTTCT
CTTTCTTTCT 3′ and the reverse was 5′GTGTGGGTC
TTCTTTTCCTTTTTC3′; the forward primer of CpsA
was 5′ AGTGGTAACTGCGTTAGTCC3′ and the reverse
was 5′CTGCCAAGTAAGACGAACTC3′ [17]; and the
forward primer of 16s rRNA was 5′GGTGAGTAACGC
GTAGGTAA3′ and the reverse was 5′ACGATCCGAAAA
CCTTCTTC3′ [18]. PCR was performed with reaction
mixtures containing 2.5 mM dNTP, 10 mM sense and anti-
sense primers, and 5 units/ml TaqDNA polymerase in
a thermal cycler for 30 seconds at 94°C, 30 seconds at 58°C
(16 s rRNA), 56°C (PsaA), 65°C (CpsA), and 1 min at 72°C,
35 cycles; the final extension reaction was carried out at
72°C for 5 min.
Statistical analysis
All data were analyzed by SPSS17.0 statistical software
(IBM Corporation, NY, USA).
The Kolmogorov-Smirnov test was used for normal ana-
lysis. The Levene test was used for the two-sample homo-
geneity of variance test. One-sample t test was used for the
comparison of the expression of virulence genes between
clinical SP (including blood-derived SP and sputum-derived
SP) and ATCC group. Factorial design analysis of variance
was used for comparison between blood-derived SP and
sputum-derived SP after stimulation. In addition, the two-
sample t test was used for comparison of two groups before
stimulation. The criterion of normality test was P < 0.10,
which was also for the homogeneity of variance test. The
criterion of significant difference of mean comparison was
P < 0.05.
Results
The expression of virulence gene PsaA in Streptococcus
pneumoniae was highly increased after THP-1 and A549
cells were stimulated
The THP-1 and A549 cells were infected by SP, and we
took pictures at 0 h, 4 h and 8 h to observe the morpho-
logical changes. SP was clearly observed 4 h after THP-1
Figure 2 The expression of PsaA gene in THP-1 (A) and A549
(B) cells at 0 hours, 4 hours, and 8 hours.
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dead after 8 h (Figure 1). The expression of virulence gene
PsaA was detected by real-time RT-PCR after THP-1 and
A549 cells were stimulated by SP for 0 h, 4 h, 8 h; all Ct
values were normalized to the Ct of 16S rRNA and
expressed as mean ± SD.
For THP-1 cells, compared with the ATCC49619 group,
the mRNA level of PsaA was lower initially in blood-
derived and sputum-derived SP, but continued increasing
after stimulation for 8 h. Virulence gene PsaA expression
was increased in blood-derived and sputum-derived SP
(ΔCt were 29.9 ± 2.4, 20.3 ± 2.8, 18.4 ± 1.0 in blood-derived
SP group at the time points of 0, 4, 8 h, respectively, and
29.7 ± 2.2, 22.1 ± 2.7, 20.7 ± 2.4 in sputum-derived SP group
at the time points of 0, 4, 8 h, respectively), while the ex-
pression of PsaA in ATCC 49619 strains was decreased
(ΔCt increased from 19.2 at 0 h to 21.5 at 4 h and 26.8 at
8 h) (Figure 2A). At 8 h, PsaA mRNA level in blood-
derived and sputum-derived SP groups was significantly el-
evated compared with ATCC 49619 strain (P < 0.05).
Factorial design analysis of variance was used for
analysis of blood- and sputum-derived group compari-
sons. Results showed there was a significant difference
(F = 5.066, P = 0.030) between blood- and sputum-derived
group between 4 h and 8 h, while the interaction between
the two groups and stimulation time point has no statis-
tical significance (F = 0.111, P = 0.741).
In general, there was a significant difference of PsaA ex-
pression at 8 h when compared with expression at 4 h in
clinically derived SP strains after THP-1 cells were stimu-
lated; longer stimulating time further enhanced the SP
PsaA expression, and when compared at the same stimu-
lated time point, the expression of plasma-derived SP
virulence gene PsaA was higher than the expression of the
sputum-derived SP strains inTHP-1 cells. As we can see
from Figure 2B, the expression of PsaA was increased in
A540 cell after being stimulated by these three SP strains.
The expression reached 19.2, 14.6, and 9.8 of ΔCt valueFigure 1 Morphological changes of THP-1 and A549 cells after Strepto
die after infection at 4 to 8 hours: A) THP-1 at 0 hours; B) THP-1 at 4 hours
at 8 hours. (×200).for ATCC49619 strain after being stimulated for 0 h, 4 h
and 8 h separately; the mean expression in blood-derived
SP strains was 28.9 ± 1.9, 15.1 ± 3.4, and 12.6 ± 3.1 at 0 h,
4 h and 8 h separately; and the expression of sputum-
derived SP strains was 27.7 ± 2.1, 16.4 ± 3.8, and 14.7 ± 3.8
at 0 h, 4 h and 8 h separately.
The PsaA expression level showed no significant dif-
ference at 4 h in these three groups, and the expression
at 8 h showed a higher level of PsaA expressed in the
blood-derived and sputum-derived SP groups compared
with ATCC 49619 strain (P < 0.05) in A549 cells.
There was a significant difference (F = 4.132, P = 0.048)
between blood- and sputum-derived groups between 4 hcoccus pneumoniae (SP) infection. THP-1 and A549 cells began to
; C) THP-1 at 8 hours; D) A549 at 0 hours; E) A549 at 4 hours; F), A549
Figure 3 The expression of CpsA gene in THP-1 (A) and A549
(B) cells at 0 hours, 4 hours, and 8 hours.
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and stimulation time point showed no statistical signifi-
cance (F = 0.176, P = 0.677).
In general, there was a significant difference of PsaA
expression at 8 h when compared with expression at 0 h
in clinically derived SP strains after A549 cells were
stimulated; longer stimulating time further enhanced
the SP PsaA expression; and when compared at the
same stimulated time point, the expression of clinically
derived SP virulence gene PsaA was lower than the ex-
pression of the ATCC49619 strain inA549 cells.
The expression of virulence gene CpsA was highly
increased after Streptococcus pneumoniae stimulated
THP-1 and A549 cells
Table 1 and Figure 3 showed the expression of the CpsA
gene in these three strains after they stimulated THP-1
and A549 cells. For THP cells, the expression increased
after clinically derived SP strains stimulated THP-1 for 4 h
and decreased after 8 h; there was significant difference inTable 1 The expression of virulence gene CpsA of Streptococc
and A549 cells
Group Number THP-1(ΔCta, mean
0 hours 4 hours
ATCC49619 1 9.8 11.7
Blood-derived SP 11 24.0 ± 2.1b 14.6 ± 6.2
Sputum-derived SP 12 23.9 ± 2.2b 16.9 ± 4.9
aΔ Ct = Mean Ct of tested gene - Mean Ct of control gene.
bP < 0.05, compared with ATCC49619 at same time point.the ΔCt values of the CpsA gene between clinical and
ATCC49619 SP strains at 0 and 8 h (P < 0.05).
For THP1 cells, there was no significant difference be-
tween blood- and sputum-derived groups between 4 h and
8 h, and the interaction between the two groups and stimu-
lation time point has no statistical significance as well.
For A549 cells, the expression of CpsA gradually in-
creased after blood-derived SP stimulated A549 cells,
and reached to the maximum at 8 h. The expression of
CpsA was increased within 4 h, and then decreased
slightly after sputum-derived SP stimulated A549 cells.
There was significant difference in the ΔCt values of the
CpsA gene between clinical and ATCC49619 SP strains
at 0 and 8 h (P < 0.05).
For A549 cells, there was no significant difference be-
tween blood- and sputum-derived groups between 4 h
and 8 h, and the interaction between the two groups and
stimulation time point showed no statistical significance
as well.
Discussion
SP surface adhesion A (PsaA) is a lipoprotein on the sur-
face of SP with the molecular weight of 37 kD [19]. It
can adhere to the mucosal cells and other cells. With
high homology to other streptococcal pilus, PsaA also
can stimulate the body to generate protective antibodies
to the infection of the lethal SP [20]. Our study showed
that the expression of PsaA significantly increased in
blood-derived and sputum-derived SP after they stimu-
lated THP-1 cells, that the expression of PsaA was signifi-
cantly different between the clinical SP and ATCC49619
groups, and that the PsaA expression was significantly
higher in blood-derived SP group than that of sputum-
derived SP group when THP-1 cells were stimulated for
8 h. These data indicate that the expression of PsaA in
blood-derived SP was much more fatal than that of
sputum-derived SP after infection for 8 h. The increased
expression of PsaA contributed greatly to SP colonization,
and it can work with other virulence factors to antagonize
the stress of THP-1 cells. This may be one of the reasons
that the blood-derived SP invades the blood system.
The expression of PsaA also increased in blood-
derived and sputum-derived SP after A549 cells were
stimulated, and the expression of PsaA was significantlyus pneumoniae (SP) before and after stimulation of THP-1
± SD.) A549(ΔCt, mean ± SD.)
8 hours 0 hours 4 hours 8 hours
25.3 9.8 17.6 11.7
17.1 ± 4.2b 24.0 ± 2.1b 16.5 ± 4.7 15.1 ± 3.0b
18.8 ± 2.6b 23.9 ± 2.2b 15.1 ± 4.6 16.8 ± 5.0b
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Same as THP-1, blood-derived SP strain showed a higher
expression of virulence genes of PsaA than sputum-
derived SP strains. Therefore, on the other hand, it also
explained that elevated PsaA expression may be a factor in
blood-derived SP invading the blood system.
The capsule is the most important virulence factor of
SP, and more than 90 different serotypes have been found
so far [21,22]. The importance of the SP capsule for viru-
lence was demonstrated by the facts that (i) all the clinical
isolates causing invasive disease are encapsulated; (ii) loss
of the capsule by either genetic mutation or enzymatic
degradation dramatically reduces virulence in animal
models of infection [4,23-25]; (iii) different capsular sero-
types vary in the ability to cause invasive diseases [26] and
swapping capsular serotypes between strains affects viru-
lence in animal models [27]; and (iv) opaque-phase variants
(which expressed thicker capsule than transparent-phase
variants) predominate during invasive infection [28].
The capsule can protect SP from complement-mediated
phagocytosis and neutrophil clearance, which contribute
to the occurrence and development of SP infection
[29,30]. The Cps gene is responsible for the synthesis of
SP capsular polysaccharide and the expression of CpsA
was significantly different in this study between clinical SP
and ATCC49619 after they stimulated THP-1 and A549
cells. The virulence gene CpsA expression levels were con-
sistent between blood-derived and sputum-derived SP; this
result demonstrated that the CpsA gene is necessary and
provides the basis of pathogenesis for clinical SP.
ATCC49619 is a standard strain that has relative stability
of physicochemical properties. Because of being isolated in
external environment, it receives no influence from the ex-
ternal bacteria such as transformation and transduction,
and when compared with clinical SP, ATCC49619 is a
lower virulent strain with weaker survival ability.
Conclusions
In general, the difference of virulence gene expressions be-
tween blood-derived and sputum-derived SP was demon-
strated 8 h after THP-1 and A549 cells were stimulated.
The results revealed that the alienation of virulence gene
expression in different sources of clinical SP displays pres-
sure to survive. Many virulence genes contribute to the in-
vasion of SP; however, our study only demonstrates this
for two of them-PsaA and CpsA genes. Thus, synergistic
effect and correlation of these virulence factors is neces-
sary for our future work.
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